TRCT
HSCS icon

Tower Research Capital (TRC)’s Heart Test Laboratories HSCS Stock Holding History

Tower Research Capital (TRC)’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.16K Buy
2,051
+542
+36% +$1.58K ﹤0.01% 4136
2025
Q4 		$4.66K Buy
1,509
+1,337
+777% +$3.97K ﹤0.01% 4191
2025
Q3 		$599 Sell
172
-493
-74% -$1.79K ﹤0.01% 4977
2025
Q2 		$2.49K Sell
665
-718
-52% -$2.51K ﹤0.01% 4641
2025
Q1 		$3.9K Buy
1,383
+1,283
+1,283% +$4.29K ﹤0.01% 4331
2024
Q4 		$382 Sell
100
-1,777
-95% -$6.1K ﹤0.01% 5301
2024
Q3 		$9.1K Buy
1,877
+1,301
+226% +$4.76K ﹤0.01% 3905
2024
Q2 		$3K Sell
576
-49
-8% -$389 ﹤0.01% 4940
2024
Q1 		$7.31K Buy
625
+502
+408% +$6.56K ﹤0.01% 4226
2023
Q4 		$2.11K Buy
+123
New +$3.03K ﹤0.01% 5273
2023
Q3 		– Sell
-9
Closed -$812 – 6058
2023
Q2 		$812 Sell
9
-16
-64% -$1.56K ﹤0.01% 5543
2023
Q1 		$2K Sell
25
-45
-64% -$6.08K ﹤0.01% 5356
2022
Q4 		$6K Buy
+70
New +$11K ﹤0.01% 4720
2022
Q3 		– Sell
-17
Closed -$3K – 6241
2022
Q2 		$3K Buy
+17
New +$3.29K ﹤0.01% 5378

Other funds holding HSCS

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
TA
TFB Advisors Overland Park, Kansas $191M AUM 18.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TWM
Tradition Wealth Management Edina, Minnesota $1.41B AUM 19.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Tower Research Capital (TRC)'s HSCS Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Heart Test Laboratories (HSCS) stake by 36% in Q1 2026, buying an estimated $1.58K and bringing the position to 2,051 shares worth $5.16K. The position accounts for ﹤0.01% of the portfolio, ranked #4136.

Tower Research Capital (TRC) first reported a position in HSCS in Q2 2022 and has held it in 14 quarters since. The position peaked at $9.1K in Q3 2024. 13 funds tracked by Wall St. Rank hold HSCS as of Q1 2026.

  • Tower Research Capital (TRC) held 2,051 shares of Heart Test Laboratories worth $5.16K as of Q1 2026.
  • Tower Research Capital (TRC) bought 542 Heart Test Laboratories shares in Q1 2026, an estimated $1.58K.
  • Heart Test Laboratories made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4136 holding.
  • Tower Research Capital (TRC) first reported a position in Heart Test Laboratories in Q2 2022 and has held it in 14 quarters since.
  • Tower Research Capital (TRC)'s Heart Test Laboratories position peaked at $9.1K in Q3 2024.
  • 13 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.